Terazosin Capsule
Product Images NDC 50268-765

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 50268-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1mg (764 15 1mg)

NDC 50268-764-15 is a prescription drug that comes in the form of capsules. The drug's active ingredient is Terazosin Hydrochloride, and each capsule contains 1 mg of the ingredient. The drug is packaged in a bottle that holds 50 unit dose capsules. The Ustal Dosage information is available in the package information sheet. The drug should be stored at a temperature of 20 - 25°C and protected from light and moisture.*

FDA Label Image

2mg (765 15 2mg)

This is a description for a medication called Terazosin, which comes in capsule form with NDC code 50268-765-15 and contains 2mg of Terazosin hydrochloride equivalent to terazosin 2mg. It is available only with a prescription and comes in a bottle of 50 capsules with unit dose of 5 x 10. The recommended dosage information is available inside the package. It is advised to protect the capsules from light and moisture and store them at 20° - 25°C (68° - T7°F). A pharmacist should dispense the medication with a patient information sheet.*

FDA Label Image

5mg (766 15 5mg)

This is a prescription medication with NDC number 50268-766-15. It is Terazosin, an FDA approved drug that is commonly used to treat hypertension (high blood pressure) and enlarged prostates. It comes in capsules of USP standards, containing 5mg of Terazosin hydrochloride equivalent to Terazosin. The recommended dosage is provided in the package insert. It is available in a unit dose of 50 capsules, with each pack holding 5x10 capsules. It should be stored between 20° - 25°. A pharmacist should dispense the medication along with patient information sheet.*

FDA Label Image

10mg (767 15 10mg)

This is a prescription drug with the NDC code 50268-767-15. The drug is Terazosin Hydrochloride and comes in capsules with each capsule containing 10 mg Terazosin. The usual dosage is not mentioned and should be taken as per the prescription. The drug should be protected from light and moisture and must be stored at 20° - 25° Celsius. The text also mentions that full prescribing information can be found inside the package.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

This text only provides a header for a graph or table, indicating that it shows the mean change from baseline in some measurement over time, at various intervals (months 0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30). No additional information is available, such as what was being measured or what the changes represent.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

This appears to be a graph or chart displaying changes in some variable (measured in mLsec) over the course of 30 months, with various points labeled on the x-axis. However, without additional context or information, it is impossible to provide further details or a more specific description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.